<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="96897">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01843335</url>
  </required_header>
  <id_info>
    <org_study_id>2013/359/REKnord</org_study_id>
    <nct_id>NCT01843335</nct_id>
  </id_info>
  <brief_title>Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair</brief_title>
  <official_title>Contrast-enhanced Ultrasound in Follow-up After Endovascular Aneurysm Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SINTEF Health Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      X-ray computed tomography imaging (CT) is routinely used in follow-up after endovascular
      aneurysm repair (EVAR). Contrast-enhanced ultrasound (CEUS) has been shown to give accurate
      information about endoleak after EVAR. Benefits of CEUS over CT include less radiation
      exposure, avoidance of renal function deterioration due to repeated X-ray contrast agent
      application and decrease in the cost of EVAR follow-up. This study is designed to
      investigate if results from literature are reproducible in St Olavs Hospital in Trondheim
      (Norway), to gain experience with the technique and to introduce CEUS as an alternative for
      detection of endoleak in this hospital.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection of endoleak with CEUS</measure>
    <time_frame>9 months</time_frame>
    <description>Compare CEUS with computed tomography angiography (CTA) sensitivity for detection of endoleak</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <condition>Endoleak</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients in follow-up after endovascular implantation of abdominal aortic prothesis,
        Central Norway
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  in follow-up after endovascular implantation of abdominal aortic prothesis

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Reidar Brekken, PhD</last_name>
    <role>Study Director</role>
    <affiliation>NTNU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <zip>7006</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 2, 2017</lastchanged_date>
  <firstreceived_date>April 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiovascular Diagnostic Technique</keyword>
  <keyword>Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Endoleak</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
